Muscular Dystrophies and Neurologic Diseases that Present as Myopathy




Chronic muscle weakness is a common complaint among patients seen in rheumatology and neuromuscular specialty clinics. This article focuses on adult-onset muscular dystrophies, select hereditary myopathies, and other neuromuscular conditions that must be distinguished from acquired causes of inflammatory muscle disease such as polymyositis. A few organizing principles help to focus the evaluation and narrow the differential diagnosis.


Chronic muscle weakness is a common complaint among patients seen in rheumatology and neuromuscular specialty clinics. This article focuses on adult-onset muscular dystrophies, select hereditary myopathies, and other neuromuscular conditions that must be distinguished from acquired causes of inflammatory muscle disease such as polymyositis. A few organizing principles help to focus the evaluation and narrow the differential diagnosis.


Because the onset of muscle weakness is typically quite insidious in genetically mediated conditions, the history provided by the patient may not at first fully reflect the degree and duration of muscle dysfunction. Individuals with long-standing and slowly progressive weakness are often able to make remarkable adaptations that permit them to function at home and in the workplace. These patients may not seek medical attention until some critical day-to-day function is finally severely impaired or lost. Because of this, it is important to question patients about physical performance and activity in relation to peers in childhood and adolescence, participation in organized sports or other physically demanding hobbies, and any physical accommodations that may have become necessary over time. These key areas of inquiry often establish a time course of disease that is much longer than initially reported. Family history may provide further diagnostic assistance; however, early parental death, variable penetrance of some diseases, recessive inheritance, de novo mutations, and other factors may obscure the genetic basis of a patient’s disorder. For this reason, even in the absence of family history, the possibility of a muscular dystrophy or other genetically mediated myopathy should be considered in any adult with chronic progressive muscle weakness.


The physical examination helps to eliminate other possible neurologic disorders. The appearance of the muscles and pattern of weakness is important. A proximal and symmetric distribution of weakness is most common. With a few notable exceptions discussed herein, marked asymmetry is uncommon in dystrophies and other hereditary myopathies, and should prompt consideration of central nervous system or peripheral nerve disorders. Other patterns, such as cranial or bulbar weakness and predominantly distal extremity weakness, can occasionally be observed. Prominent fasciculations or increased muscle tone are also unusual in hereditary muscle disease and suggest anterior horn cell or central nervous system disorders, respectively. Reflexes should be normal in myopathies or may be hypoactive if muscles are severely weak. Sensation should be normal, and the presence of objective sensory disturbances indicates that weakness is most likely related to peripheral nerve or central nervous system dysfunction.


Diagnostic evaluation


Once a patient is determined to have neuromuscular weakness without sensory loss, the first step is to classify the process as originating in muscle, neuromuscular junction, or motor nerves or neurons. An elevated serum creatine phosphokinase (CPK) level is common in muscle disease, but milder elevations may also be observed with muscle loss from anterior horn cell or motor nerve damage. A normal CPK value does not exclude underlying muscle disease. Neuromuscular junction disease such as myasthenia gravis and Lambert-Eaton myasthenic syndrome does not affect CPK levels, but tests for acetylcholine receptor or voltage-gated P/Q calcium channel antibodies, respectively, are quite specific. In situations where blood work is not helpful, detailed high-quality electrodiagnostic testing is another important method of differentiating among the possibilities.


Patients who have unequivocal elevations in CPK levels, for example, several thousand units per liter, require further testing for muscle disease. For individuals who manifest a clear phenotype and familial pattern, genetic testing can be performed through any of several commercial or university based laboratories listed on the www.genetests.org Web site, sponsored jointly by the National Center for Biotechnology Information, the National Institutes of Health, and the University of Washington, Seattle. In patients who have no family history or distinguishing clinical features, biopsy of a weak muscle allows for routine and specialized immunohistochemical analysis that can guide more targeted genetic testing. An adequate sample is critical, whether obtained through an open procedure or needle biopsy. The choice of muscle for biopsy is also important. A strong muscle or a severely weak muscle are both less likely to be informative than a muscle that is moderately weak. It is also important to avoid a muscle that was recently examined with needle electromyography, as localized and transient inflammation may occur, causing diagnostic confusion.


The remainder of this article considers a diagnostic approach for adults with chronic progressive muscle weakness, and discusses specific muscular dystrophies and genetically mediated myopathies with 3 main patterns of clinical presentation: limb girdle weakness, bulbar or cranial weakness, and distal weakness. Features that may help to differentiate among the more common adult-onset muscular dystrophies and genetically mediated myopathies are reviewed. Disease-specific treatments and supportive therapies are discussed.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Oct 1, 2017 | Posted by in RHEUMATOLOGY | Comments Off on Muscular Dystrophies and Neurologic Diseases that Present as Myopathy

Full access? Get Clinical Tree

Get Clinical Tree app for offline access